| 1 |
34581204 | Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients. | 2021 Oct |
2 |
| 2 |
30992538 | Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid. | 2020 Feb |
1 |
| 3 |
31742356 | Mechanisms of Metabolism Interaction Between p-Cresol and Mycophenolic Acid. | 2020 Feb 1 |
2 |
| 4 |
30976185 | Effect of pterostilbene on in vitro drug metabolizing enzyme activity. | 2019 Mar |
1 |
| 5 |
22327003 | The influence of UGT polymorphisms as biomarkers in solid organ transplantation. | 2012 Sep 8 |
2 |
| 6 |
20973683 | Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study. | 2010 Nov |
1 |
| 7 |
19225446 | UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients. | 2009 May |
1 |
| 8 |
18454993 | Influence of UDP-glucuronosyltransferase polymorphisms on mycophenolate mofetil-induced side effects in kidney transplant patients. | 2008 Apr |
3 |
| 9 |
18568343 | Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors. | 2008 Nov |
1 |
| 10 |
18651539 | Pharmacogenetics of mycophenolate mofetil: a promising different approach to tailoring immunosuppression? | 2008 Jul-Aug |
6 |
| 11 |
15470161 | Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. | 2005 Jan |
1 |